Effect of Empagliflozin on Nephropathy in Subgroups by Age: Results from EMPA-REG OUTCOME®. 2nd Cardiovascular Outcome Trial Summit of the Diabetes and Cardiovascular Disease Study Group of the European Association for the Study of Diabetes, Munich, 20 – 21 Oct 2016 (Poster) - Calabro, P; von Eynatten, M; Wanner, C (2016)